Pramipexole Completed Phase 2 Trials for Alzheimer's Disease (AD) Treatment

IndicationsStatusPurposePhase
CompletedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT01388478Safety Study of R(+)Pramipexole to Treat Early Alzheimer's Disease